| Estrogen receptor α in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor … CR Yeh, S Slavin, J Da, I Hsu, J Luo, GQ Xiao, J Ding, FJ Chou, S Yeh Molecular cancer 15, 1-14, 2016 | 65 | 2016 |
| Targeting fatty acid synthase with ASC‐J9 suppresses proliferation and invasion of prostate cancer cells S Wen, Y Niu, SO Lee, S Yeh, Z Shang, H Gao, Y Li, F Chou, C Chang Molecular carcinogenesis 55 (12), 2278-2290, 2016 | 50 | 2016 |
| Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment/M2 polarization with change of the miR-185-5p/CSF-1 … W Zhu, Z Zhao, F Chou, L Zuo, T Liu, S Yeh, D Bushinsky, G Zeng, ... Cell death & disease 10 (4), 275, 2019 | 45 | 2019 |
| Androgen receptor (AR) degradation enhancer ASC-J9® in an FDA-approved formulated solution suppresses castration resistant prostate cancer cell growth MA Cheng, FJ Chou, K Wang, R Yang, J Ding, Q Zhang, G Li, S Yeh, D Xu, ... Cancer letters 417, 182-191, 2018 | 41 | 2018 |
| Natural killer cells suppress enzalutamide resistance and cell invasion in the castration resistant prostate cancer via targeting the androgen receptor splicing variant 7 (ARv7) SJ Lin, FJ Chou, L Li, CY Lin, S Yeh, C Chang Cancer letters 398, 62-69, 2017 | 37 | 2017 |
| The Protective Roles of Estrogen Receptor β in Renal Calcium Oxalate Crystal Formation via Reducing the Liver Oxalate Biosynthesis and Renal Oxidative Stress … W Zhu, Z Zhao, FJ Chou, L Zuo, T Liu, D Bushinsky, C Chang, G Zeng, ... Oxidative Medicine and Cellular Longevity 2019 (1), 5305014, 2019 | 36 | 2019 |
| Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR B You, Y Sun, J Luo, K Wang, Q Liu, R Fang, B Liu, F Chou, R Wang, ... Oncogene 40 (9), 1674-1689, 2021 | 32 | 2021 |
| Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity D Chen, FJ Chou, Y Chen, H Tian, Y Wang, B You, Y Niu, CP Huang, ... Cancer letters 495, 100-111, 2020 | 28 | 2020 |
| Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated Gαi … J Chen, F Chou, S Yeh, Z Ou, C Shyr, C Huang, Z Xiang, Y Sun, ... Oncogene 39 (3), 574-586, 2020 | 27 | 2020 |
| Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer … FJ Chou, Y Chen, D Chen, Y Niu, G Li, P Keng, S Yeh, C Chang EBioMedicine 40, 504-516, 2019 | 25 | 2019 |
| Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling Q Liu, B You, J Meng, CP Huang, G Dong, R Wang, F Chou, S Gao, ... Cancer Gene Therapy 29 (12), 1988-2000, 2022 | 20 | 2022 |
| Targeting the androgen receptor (AR) with AR degradation enhancer ASC-J9® led to increase docetaxel sensitivity via suppressing the p21 expression J Luo, J Tian, FJ Chou, C Lin, EZ Xing, L Zuo, Y Niu, S Yeh, C Chang Cancer Letters 444, 35-44, 2019 | 18 | 2019 |
| Olaparib and enzalutamide synergistically suppress HCC progression via the AR-mediated miR-146a-5p/BRCA1 signaling J Zhao, Y Sun, H Lin, F Chou, Y Xiao, R Jin, X Cai, C Chang FASEB journal: official publication of the Federation of American Societies …, 2020 | 17 | 2020 |
| R26R-GR: A Cre-Activable Dual Fluorescent Protein Reporter Mouse YT Chen, MS Tsai, TL Yang, AT Ku, KH Huang, CY Huang, FJ Chou, ... Public Library of Science 7 (9), e46171, 2012 | 17 | 2012 |
| Preclinical studies using cisplatin/carboplatin to restore the Enzalutamide sensitivity via degrading the androgen receptor splicing variant 7 (ARv7) to further suppress … FJ Chou, CY Lin, H Tian, WY Lin, B You, J Lu, D Sahasrabudhe, ... Cell death & disease 11 (11), 942, 2020 | 14 | 2020 |
| ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling H Tian, F Chou, J Tian, Y Zhang, B You, CP Huang, S Yeh, Y Niu, ... Journal of Experimental & Clinical Cancer Research 40, 1-12, 2021 | 12 | 2021 |
| New therapy with ASC-J9® to suppress the prostatitis via altering the cytokine CCL2 signals SJ Lin, FJ Chou, CY Lin, HC Chang, S Yeh, C Chang Oncotarget 7 (41), 66769, 2016 | 7 | 2016 |
| A nucleolus-predominant piggyBac transposase, NP-mPB, mediates elevated transposition efficiency in mammalian cells JB Hong, FJ Chou, AT Ku, HH Fan, TL Lee, YH Huang, TL Yang, IC Su, ... Plos one 9 (2), e89396, 2014 | 7 | 2014 |
| Targeting the radiation-induced ARv7-mediated circNHS/miR-512-5p/XRCC5 signaling with Quercetin increases prostate cancer radiosensitivity D Chen, FJ Chou, Y Chen, CP Huang, H Tian, Y Wang, Y Niu, B You, ... Journal of Experimental & Clinical Cancer Research 41 (1), 235, 2022 | 6 | 2022 |
| Preclinical studies show using enzalutamide is less effective in docetaxel-pretreated than in docetaxel-naïve prostate cancer cells C Lin, FJ Chou, J Lu, W Lin, M Truong, H Tian, Y Sun, J Luo, R Yang, ... Aging (Albany NY) 12 (17), 17694, 2020 | 4 | 2020 |
